Breast Cancer Vaccine in early clinical trials

Breast cancer is the most common cancer in women nationwide. Accounting for 1 in 3 new cases each year. But there is new hope. San Jose based Anixa Biosciences has partnered with the Cleveland Clinic on a vaccine that targets triple negative breast cancer. Dr. Amit Kumar, CEO of Onyx Biosciences, joined us on The Nine for more.